Genesis Biopharma, Inc·4

Sep 30, 3:25 PM ET

Schroeder Martin 4

4 · Genesis Biopharma, Inc · Filed Sep 30, 2011

Insider Transaction Report

Form 4
Period: 2011-08-22
Transactions
  • Award

    Common Stock

    2011-08-22$1.13/sh+1,000,000$1,130,0001,000,000 total(indirect: By LLC)
Footnotes (2)
  • [F1]Shares were granted for services rendered to the Company.
  • [F2]Mr. Schroeder is Executive Vice President and Managing Director of the Emmes Group, Inc., a strategic business consulting firm.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT